Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase Peptide Synthesis (SPPS) . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108676087A reveals a novel Depsipeptide strategy for Semaglutide. This method enhances purity and yield, offering significant cost reduction in peptide manufacturing for global supply chains.
Patent CN102180964B reveals a high-yield solid-phase synthesis for Human Relaxin-2. Achieve 74-82% yield with simplified Fmoc strategies for reliable pharmaceutical intermediate supply.
Patent CN115109118A introduces a solid-phase synthesis method for DS-8201 intermediates, offering superior purity and cost reduction for ADC manufacturing.
Novel fragment condensation method for Tesamorelin improves purity and yield. Ideal for pharmaceutical intermediates manufacturing and large-scale production.
Discover the novel Alloc-protected solid-phase synthesis of Somatostatin KE108. Eliminating hydrogen hazards for safer, scalable pharmaceutical intermediate production.
Patent CN112538103B reveals a safer, hydrogen-free synthesis route for Somatostatin KE108 using Alloc protection, offering significant cost reduction in peptide manufacturing.
Patent CN113801199A details a novel Mitsunobu cyclization for Carbetocin. Discover cost-effective, scalable solid-phase manufacturing solutions for this oxytocin analogue.
Patent CN114230653B reveals a novel fragment coupling method for Chlorotoxin, achieving >99% purity. Discover cost-effective manufacturing strategies for this tumor-targeting peptide intermediate.
Patent CN114685645A details a novel Semaglutide synthesis using NCL and desulfurization, offering improved purity and cost reduction for API manufacturing.
Advanced synthetic route for Daptomycin antibiotic using solid-liquid phase combination. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN103880945A details a novel fragment condensation method for Thymalfasin, offering >99% purity and enhanced scalability for reliable pharmaceutical intermediate supply chains.
Patent CN104497130A reveals a novel 2+6 segment condensation method for Lanreotide, enhancing purity and yield for cost-effective peptide manufacturing supply chains.
Patent CN103214568A details a novel Fmoc solid-phase method using pseudo-proline dipeptides to enhance yield and purity for industrial secretin production.
Patent CN112194708A details a novel Procatide synthesis using FMPB-modified resin and stepwise disulfide bonding, ensuring high purity and yield for reliable supply chains.
Novel fragment condensation method for Gelpaglutide improves crude purity to over 75 percent and total yield to nearly 30 percent, offering significant cost reduction in polypeptide manufacturing.
Patent CN113748125A details a robust solid-phase method for Liraglutide and Semaglutide. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN112125970A reveals a novel solid-phase synthesis for Semaglutide using specialized Asp protection and fragment condensation to enhance yield and purity for reliable API manufacturing.
Patent CN112521482A reveals a solid-liquid combined method for nesiritide. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Novel solid-phase synthesis method for Omega-Conotoxin GVIA. Enhances disulfide bond accuracy and yield for pharmaceutical intermediates supply chain.
Patent CN102875665A reveals a high-yield fragment condensation method for Liraglutide, offering superior purity and cost-effective manufacturing alternatives to recombinant technologies.